Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

recombinant fowlpox-CEA(6D)/TRICOM vaccine

A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:fowlpox-CEA-B7-1/ICAM-1/LFA-3
rF-CEA(6D)TRICOM
IND number:9306
NSC code:710068
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search